International Regulatory Collaboration on the Analysis of Nitrosamines in Metformin-Containing Medicines

Recalls of some batches of metformin have occurred due to the detection of N -nitrosodimethylamine (NDMA) in amounts above the acceptable intake (AI) of 96 ng per day. Prior to the recalls, an international regulatory laboratory network had been monitoring drugs for nitrosamine impurities with each...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	The AAPS journal Ročník 24; číslo 3; s. 56
Hlavní autori:	Keire, David A., Bream, Robert, Wollein, Uwe, Schmaler-Ripcke, Jeannette, Burchardt, Annette, Conti, Massimiliano, Zmysłowski, Adam, Keizers, Peter, Morin, Justin, Poh, Jalene, George, Mark, Wierer, Michael
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Cham Springer International Publishing 21.04.2022 Springer
Predmet:	Biochemistry Biomedical and Life Sciences Biomedicine Biotechnology Diabetes therapy Dimethylnitrosamine - analysis Humans Independent regulatory commissions Metformin Metformin - analysis Nitrosamines - analysis Nitrosoamines Pharmacology/Toxicology Pharmacy Research Article Type 2 diabetes Valsartan metformin drug supply nitrosamines NDMA International regulatory laboratories
ISSN:	1550-7416, 1550-7416
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!